Detalhe da pesquisa
1.
Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN).
Ann Oncol
; 29(4): 985-991, 2018 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29346507
2.
Pazopanib in advanced germ cell tumors after chemotherapy failure: results of the open-label, single-arm, phase 2 Pazotest trial.
Ann Oncol
; 28(6): 1346-1351, 2017 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28383677
3.
Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology.
Eur J Nucl Med Mol Imaging
; 42(11): 1718-1738, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26112387
4.
Analysis of plasma cytokines and angiogenic factors in patients with pretreated urothelial cancer receiving Pazopanib: the role of circulating interleukin-8 to enhance the prognostic accuracy.
Br J Cancer
; 110(1): 26-33, 2014 Jan 07.
Artigo
Inglês
| MEDLINE | ID: mdl-24231947
5.
PF-03446962, a fully-human monoclonal antibody against transforming growth-factor ß (TGFß) receptor ALK1, in pre-treated patients with urothelial cancer: an open label, single-group, phase 2 trial.
Invest New Drugs
; 32(3): 555-60, 2014 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-24566706
6.
Phase II study on lapatinib in advanced EGFR-positive chordoma.
Ann Oncol
; 24(7): 1931-1936, 2013 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-23559153
7.
Point mutations and a large intragenic deletion in SPG11 in complicated spastic paraplegia without thin corpus callosum.
J Med Genet
; 46(5): 345-51, 2009 May.
Artigo
Inglês
| MEDLINE | ID: mdl-19196735
8.
Response to imatinib plus sirolimus in advanced chordoma.
Ann Oncol
; 20(11): 1886-94, 2009 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-19570961
9.
Early reduction of serum TARC levels may predict for success of ABVD as frontline treatment in patients with Hodgkin Lymphoma.
Leuk Res
; 62: 91-97, 2017 11.
Artigo
Inglês
| MEDLINE | ID: mdl-28992524
10.
Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management.
J Natl Cancer Inst
; 93(8): 630-5, 2001 Apr 18.
Artigo
Inglês
| MEDLINE | ID: mdl-11309439
11.
A lock-in-based method to examine the thermal signatures of magnetic nanoparticles in the liquid, solid and aggregated states.
Nanoscale
; 8(27): 13321-32, 2016 Jul 21.
Artigo
Inglês
| MEDLINE | ID: mdl-27341001
12.
Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy.
J Clin Oncol
; 5(1): 27-37, 1987 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-2433409
13.
Radioimmunoscintigraphy of ovarian cancer with the MOv18 monoclonal antibody.
Eur J Cancer
; 27(6): 724-9, 1991.
Artigo
Inglês
| MEDLINE | ID: mdl-1829912
14.
Single-dose intraperitoneal radioimmunotherapy with the murine monoclonal antibody I-131 MOv18: clinical results in patients with minimal residual disease of ovarian cancer.
Eur J Cancer
; 31A(5): 686-90, 1995.
Artigo
Inglês
| MEDLINE | ID: mdl-7640039
15.
Somatostatin receptor imaging of small cell lung cancer (SCLC) by means of 111In-DTPA octreotide scintigraphy.
Eur J Cancer
; 31A(2): 184-8, 1995.
Artigo
Inglês
| MEDLINE | ID: mdl-7718323
16.
Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma.
J Nucl Med
; 41(9): 1491-4, 2000 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-10994727
17.
Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer.
J Nucl Med
; 39(1): 4-8, 1998 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-9443729
18.
Preliminary-results of preoperative axillary radioimmunoscintigraphy with in-111 b72.3 in breast-cancer.
Int J Oncol
; 6(4): 791-5, 1995 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-21556604
19.
Axillary lymph node metastases detection with nuclear medicine approaches in patients with newly diagnosed breast cancer.
Int J Oncol
; 8(4): 693-9, 1996 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-21544415
20.
Prone scintimammography in patients with non-palpable breast lesions.
Anticancer Res
; 16(3A): 1269-73, 1996.
Artigo
Inglês
| MEDLINE | ID: mdl-8702249